Custom service
Peptide Array-Based Epitope Mapping
Run array-format epitope mapping with fine-grained peptide density control
The service is built around high-density array synthesis. Depending on the molecule we may move to titrated peptide density or multiplex serum screening to improve stability, loading or yield, and every batch is released with array epitope dataset.
Because Peptide Array-Based Epitope Mapping projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Large antigen panels in parallel
Fine-specificity comparisons
Epitopes requiring post-translational context
Samples requiring containment or licensing we do not hold (BSL-3, radioactive)
Analytical reports follow a fixed template: sample condition on receipt, method description with validation status, raw chromatograms and spectra, results with uncertainty, and an interpretation note. Urgent same-week slots are available for release-critical testing.
Service Highlights
- High-density array synthesis as the default route, with titrated peptide density held as a proven fallback
- Multiplex serum screening worked into the design where the application requires it
- Results are reported with detection limits and method validation status, so you know exactly what the number means
- Analytical confirmation of every intermediate before the final release
- Orthogonal methods are used by default — one measurement is an observation, two are data
- Array epitope dataset delivered with a complete conjugation or synthesis certificate
How the work runs
Sample intake & plan
Samples are logged with chain of custody and the test matrix for Peptide Array-Based Epitope Mapping is confirmed.
Method selection
Analytical methods — high-density array synthesis, titrated peptide density — are chosen and their validation status documented.
Measurement
Testing is executed with system-suitability checks and orthogonal confirmation where required.
Data review
Chromatograms and spectra are reviewed by a second analyst before any result is issued.
Reporting
Array epitope dataset is issued with detection limits and interpretation notes.
Follow-up support
We discuss anomalies and, where useful, propose the follow-up experiment that resolves them.
Specifications & timeline
- Turnaround
- 4–7 weeks
- Typical scale
- µg – g sample scale
- Chemistry options
- high-density array synthesis; titrated peptide density; multiplex serum screening
- Deliverable
- Array epitope dataset
- QC package
- Method report, raw data, validated result with detection limits
- Shipping
- Blue ice or ambient by material; chain-of-custody on receipt
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.